Galectin-8, Recombinant, Human (LGALS8, Gal-8, Po66 Carbohydrate-binding Protein, Po66-CBP, PCTA-1, Prostate Carcinoma Tumor Antigen 1)

Catalog No : USB-G1044-61
508.06€
0.00€

Shipping cost plus VAT not included , delivery in 7-14 business days

Product name Galectin-8, Recombinant, Human (LGALS8, Gal-8, Po66 Carbohydrate-binding Protein, Po66-CBP, PCTA-1, Prostate Carcinoma Tumor Antigen 1)
Catalog No USB-G1044-61
Supplier’s Catalog No G1044-61
Supplier US Biologicals
Source antigen Recombinant, E. coli
Reactivity
Cross reactivity
Applications
Molecular weight 37.9
Storage -20°C
Other names
Grade Purified
Purity ~90% (SDS-PAGE).
Form Supplied as a liquid in 20mM Tris-HCl, pH 8.0, 0.1M sodium chloride, 1mM DTT, 10% glycerol.
Reactivity life 6 months
Note For reserch purpose only
Purity ~90% (SDS-PAGE).
Description LGALS8, also known as prostate-specific membrane antigen (PCTA1), is an additional prostate-specific antigen that is overexpressed only in malignant tumors and therefore is a more specific identifier of malignancies. It is a member of the galectin gene family which mediates both cell-cell and cell matrix interactions in a manner similar to the selectin subgroup of C-type lectins. Recombinant corresponding to aa1-379 of human LGALS8 protein, fused to His-tag at N-terminus, expressed in E.coli. Biological activity: The ED50 for this effect is is 5-10ug/ml, measured by its ability to agglutinate human red blood cells. Amino Acid Sequence: MGSSHHHHHH SSGLVPRGSH MMLSLNNLQN IIYNPVIPFV GTIPDQLDPG TLIVIRGHVP SDADRFQVDL QNGSSMKPRA DVAFHFNPRF KRAGCIVCNT LINEKWGREE ITYDTPFKRE KSFEIVIMVL KDKFQVAVNG KHTLLYGHRI GPEKIDTLGI YGKVNIHSIG FSFSSDLQST QASSLELTEI SRENVPKSGT PQLRLPFAAR LNTPMGPGRT VVVKGEVNAN AKSFNVDLLA GKSKDIALHL NPRLNIKAFV RNSFLQESWG EEERNITSFP FSPGMYFEMI IYCDVREFKV AVNGVHSLEY KHRFKELSSI DTLEINGDIH LLEVRSW Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing.. Store at -20°C. Aliquots are stable for 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.